Loading…

Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer

Risk factors vary in terms of the pattern of lung cancer metastasis and specific metastatic organs. In this study, we retrospectively analyzed the clinical risk factors of tumor metastasis in lung cancer patients and used second‐generation gene sequencing to characterize relevant gene mutations. The...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2022-01, Vol.11 (1), p.268-280
Main Authors: Wang, Bin, Chen, Shu, Xiao, He, Zhang, Jiao, Liang, Dandan, Shan, Jinlu, Zou, Hua
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73
cites cdi_FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73
container_end_page 280
container_issue 1
container_start_page 268
container_title Cancer medicine (Malden, MA)
container_volume 11
creator Wang, Bin
Chen, Shu
Xiao, He
Zhang, Jiao
Liang, Dandan
Shan, Jinlu
Zou, Hua
description Risk factors vary in terms of the pattern of lung cancer metastasis and specific metastatic organs. In this study, we retrospectively analyzed the clinical risk factors of tumor metastasis in lung cancer patients and used second‐generation gene sequencing to characterize relevant gene mutations. The risk factors of different metastatic sites of real‐world lung cancer were explored to find the differentially expressed genes and risk factors in different metastatic organs, which laid a foundation for further study on the metastasis patterns and mechanisms of lung cancer. The clinical risk factors of tumor metastasis in 137 lung cancer patients who attended our department from May 2017 to March 2019 were retrospectively analyzed and grouped based on bone metastasis, brain metastasis, other distant metastasis, and no metastasis. Single‐ or multi‐factor logistic regression analysis was performed to analyze the effect of neutrophil/lymphocyte ratio/platelet/lymphocyte ratio/lymphocyte to monocyte ratio on platelets (PLTs) and bone metastasis by combining PLT values, age, pathology type, gender, and smoking history. Based on the presence or absence of bone metastasis, distal metastasis, and PLT values of lung cancer, 39 tissue specimens of primary lung cancer were taken for 773 gene grouping and gene mutation characterization. The tumor mutation load, gene copy number instability, microsatellite instability, and tumor heterogeneity among different groups were analyzed. Age and PLT level were independent risk factors for bone metastasis and distal metastasis, but not for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated PLT group. PLT values were an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. RB1 gene mutation was significantly associated with bone metastasis. Age and platelet level were independent risk factors for bone metastasis and distal bone metastasis, but age and platelet level were not risk factors for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated platelet group. Platelet values are an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. Mutations in the RB1 gene are significantly associated with bone metastasis.
doi_str_mv 10.1002/cam4.4424
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0ce17a141e1344789754da4907e54a5c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0ce17a141e1344789754da4907e54a5c</doaj_id><sourcerecordid>2600287798</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73</originalsourceid><addsrcrecordid>eNp1kk1v3CAQQK2qURMlOfQPVEi9tIdNAIOxL5VWq35ESpVLekZjGDtsbUjBTrX_vng3jZJK5QJiHo8ZzRTFW0YvGKX80sAoLoTg4lVxwqmQK1WV4vWz83FxntKW5qUorxR7UxyXQjV5qZOiX3sYdsklEjoSXfpJOjBTiImAt6RHj2ScJ5hc8MTcQcxBzNjkzP6FdV2HEf1ERpwgLaAhyU24jw6z74kBbzCeFUcdDAnPH_fT4seXz7ebb6vrm69Xm_X1ykjaiJUxLTSqyrnZDjsJDRfWGmaRSV7aplXQtbJRvKbcGqywVlJSxltQudLWqvK0uDp4bYCtvo9uhLjTAZzeX4TYa4g5yQE1NcgUMMGQlUKoulFSWBANVSgFSJNdnw6u-7kdMf_npwjDC-nLiHd3ug8PulZUMEmz4MOjIIZfM6ZJjy4ZHAbwGOakeZUbWCvV1Bl9_w-6DXPMvVkoVrKl_jJTHw-UiSGliN1TMozqZRr0Mg16mYbMvnue_RP5t_cZuDwAv92Au_-b9Gb9XeyVfwBEIL8o</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2613115233</pqid></control><display><type>article</type><title>Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley-Blackwell Titles (Open access)</source><source>PubMed Central(OpenAccess)</source><creator>Wang, Bin ; Chen, Shu ; Xiao, He ; Zhang, Jiao ; Liang, Dandan ; Shan, Jinlu ; Zou, Hua</creator><creatorcontrib>Wang, Bin ; Chen, Shu ; Xiao, He ; Zhang, Jiao ; Liang, Dandan ; Shan, Jinlu ; Zou, Hua</creatorcontrib><description>Risk factors vary in terms of the pattern of lung cancer metastasis and specific metastatic organs. In this study, we retrospectively analyzed the clinical risk factors of tumor metastasis in lung cancer patients and used second‐generation gene sequencing to characterize relevant gene mutations. The risk factors of different metastatic sites of real‐world lung cancer were explored to find the differentially expressed genes and risk factors in different metastatic organs, which laid a foundation for further study on the metastasis patterns and mechanisms of lung cancer. The clinical risk factors of tumor metastasis in 137 lung cancer patients who attended our department from May 2017 to March 2019 were retrospectively analyzed and grouped based on bone metastasis, brain metastasis, other distant metastasis, and no metastasis. Single‐ or multi‐factor logistic regression analysis was performed to analyze the effect of neutrophil/lymphocyte ratio/platelet/lymphocyte ratio/lymphocyte to monocyte ratio on platelets (PLTs) and bone metastasis by combining PLT values, age, pathology type, gender, and smoking history. Based on the presence or absence of bone metastasis, distal metastasis, and PLT values of lung cancer, 39 tissue specimens of primary lung cancer were taken for 773 gene grouping and gene mutation characterization. The tumor mutation load, gene copy number instability, microsatellite instability, and tumor heterogeneity among different groups were analyzed. Age and PLT level were independent risk factors for bone metastasis and distal metastasis, but not for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated PLT group. PLT values were an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. RB1 gene mutation was significantly associated with bone metastasis. Age and platelet level were independent risk factors for bone metastasis and distal bone metastasis, but age and platelet level were not risk factors for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated platelet group. Platelet values are an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. Mutations in the RB1 gene are significantly associated with bone metastasis.</description><identifier>ISSN: 2045-7634</identifier><identifier>EISSN: 2045-7634</identifier><identifier>DOI: 10.1002/cam4.4424</identifier><identifier>PMID: 34799997</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Age ; Blood ; Bone growth ; Bone tumors ; Brain cancer ; Cancer Prevention ; Copy number ; gene mutation characteristics ; Genes ; Genomes ; Leukocytes (neutrophilic) ; Lung cancer ; Lymphocytes ; Medical prognosis ; Metastases ; Metastasis ; metastatic sites ; Microsatellite instability ; Monocytes ; Mutation ; Patients ; Platelets ; Point mutation ; Regression analysis ; Retinoblastoma protein ; Risk factors ; Software ; Tumors</subject><ispartof>Cancer medicine (Malden, MA), 2022-01, Vol.11 (1), p.268-280</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2021 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73</citedby><cites>FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73</cites><orcidid>0000-0002-4817-1074</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2613115233/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2613115233?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11542,25732,27903,27904,36991,36992,44569,46031,46455,53770,53772,74873</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34799997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Bin</creatorcontrib><creatorcontrib>Chen, Shu</creatorcontrib><creatorcontrib>Xiao, He</creatorcontrib><creatorcontrib>Zhang, Jiao</creatorcontrib><creatorcontrib>Liang, Dandan</creatorcontrib><creatorcontrib>Shan, Jinlu</creatorcontrib><creatorcontrib>Zou, Hua</creatorcontrib><title>Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer</title><title>Cancer medicine (Malden, MA)</title><addtitle>Cancer Med</addtitle><description>Risk factors vary in terms of the pattern of lung cancer metastasis and specific metastatic organs. In this study, we retrospectively analyzed the clinical risk factors of tumor metastasis in lung cancer patients and used second‐generation gene sequencing to characterize relevant gene mutations. The risk factors of different metastatic sites of real‐world lung cancer were explored to find the differentially expressed genes and risk factors in different metastatic organs, which laid a foundation for further study on the metastasis patterns and mechanisms of lung cancer. The clinical risk factors of tumor metastasis in 137 lung cancer patients who attended our department from May 2017 to March 2019 were retrospectively analyzed and grouped based on bone metastasis, brain metastasis, other distant metastasis, and no metastasis. Single‐ or multi‐factor logistic regression analysis was performed to analyze the effect of neutrophil/lymphocyte ratio/platelet/lymphocyte ratio/lymphocyte to monocyte ratio on platelets (PLTs) and bone metastasis by combining PLT values, age, pathology type, gender, and smoking history. Based on the presence or absence of bone metastasis, distal metastasis, and PLT values of lung cancer, 39 tissue specimens of primary lung cancer were taken for 773 gene grouping and gene mutation characterization. The tumor mutation load, gene copy number instability, microsatellite instability, and tumor heterogeneity among different groups were analyzed. Age and PLT level were independent risk factors for bone metastasis and distal metastasis, but not for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated PLT group. PLT values were an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. RB1 gene mutation was significantly associated with bone metastasis. Age and platelet level were independent risk factors for bone metastasis and distal bone metastasis, but age and platelet level were not risk factors for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated platelet group. Platelet values are an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. Mutations in the RB1 gene are significantly associated with bone metastasis.</description><subject>Age</subject><subject>Blood</subject><subject>Bone growth</subject><subject>Bone tumors</subject><subject>Brain cancer</subject><subject>Cancer Prevention</subject><subject>Copy number</subject><subject>gene mutation characteristics</subject><subject>Genes</subject><subject>Genomes</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lung cancer</subject><subject>Lymphocytes</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>metastatic sites</subject><subject>Microsatellite instability</subject><subject>Monocytes</subject><subject>Mutation</subject><subject>Patients</subject><subject>Platelets</subject><subject>Point mutation</subject><subject>Regression analysis</subject><subject>Retinoblastoma protein</subject><subject>Risk factors</subject><subject>Software</subject><subject>Tumors</subject><issn>2045-7634</issn><issn>2045-7634</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kk1v3CAQQK2qURMlOfQPVEi9tIdNAIOxL5VWq35ESpVLekZjGDtsbUjBTrX_vng3jZJK5QJiHo8ZzRTFW0YvGKX80sAoLoTg4lVxwqmQK1WV4vWz83FxntKW5qUorxR7UxyXQjV5qZOiX3sYdsklEjoSXfpJOjBTiImAt6RHj2ScJ5hc8MTcQcxBzNjkzP6FdV2HEf1ERpwgLaAhyU24jw6z74kBbzCeFUcdDAnPH_fT4seXz7ebb6vrm69Xm_X1ykjaiJUxLTSqyrnZDjsJDRfWGmaRSV7aplXQtbJRvKbcGqywVlJSxltQudLWqvK0uDp4bYCtvo9uhLjTAZzeX4TYa4g5yQE1NcgUMMGQlUKoulFSWBANVSgFSJNdnw6u-7kdMf_npwjDC-nLiHd3ug8PulZUMEmz4MOjIIZfM6ZJjy4ZHAbwGOakeZUbWCvV1Bl9_w-6DXPMvVkoVrKl_jJTHw-UiSGliN1TMozqZRr0Mg16mYbMvnue_RP5t_cZuDwAv92Au_-b9Gb9XeyVfwBEIL8o</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Wang, Bin</creator><creator>Chen, Shu</creator><creator>Xiao, He</creator><creator>Zhang, Jiao</creator><creator>Liang, Dandan</creator><creator>Shan, Jinlu</creator><creator>Zou, Hua</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4817-1074</orcidid></search><sort><creationdate>202201</creationdate><title>Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer</title><author>Wang, Bin ; Chen, Shu ; Xiao, He ; Zhang, Jiao ; Liang, Dandan ; Shan, Jinlu ; Zou, Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Blood</topic><topic>Bone growth</topic><topic>Bone tumors</topic><topic>Brain cancer</topic><topic>Cancer Prevention</topic><topic>Copy number</topic><topic>gene mutation characteristics</topic><topic>Genes</topic><topic>Genomes</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lung cancer</topic><topic>Lymphocytes</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>metastatic sites</topic><topic>Microsatellite instability</topic><topic>Monocytes</topic><topic>Mutation</topic><topic>Patients</topic><topic>Platelets</topic><topic>Point mutation</topic><topic>Regression analysis</topic><topic>Retinoblastoma protein</topic><topic>Risk factors</topic><topic>Software</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Bin</creatorcontrib><creatorcontrib>Chen, Shu</creatorcontrib><creatorcontrib>Xiao, He</creatorcontrib><creatorcontrib>Zhang, Jiao</creatorcontrib><creatorcontrib>Liang, Dandan</creatorcontrib><creatorcontrib>Shan, Jinlu</creatorcontrib><creatorcontrib>Zou, Hua</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>Wiley Free Archive</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer medicine (Malden, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Bin</au><au>Chen, Shu</au><au>Xiao, He</au><au>Zhang, Jiao</au><au>Liang, Dandan</au><au>Shan, Jinlu</au><au>Zou, Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer</atitle><jtitle>Cancer medicine (Malden, MA)</jtitle><addtitle>Cancer Med</addtitle><date>2022-01</date><risdate>2022</risdate><volume>11</volume><issue>1</issue><spage>268</spage><epage>280</epage><pages>268-280</pages><issn>2045-7634</issn><eissn>2045-7634</eissn><abstract>Risk factors vary in terms of the pattern of lung cancer metastasis and specific metastatic organs. In this study, we retrospectively analyzed the clinical risk factors of tumor metastasis in lung cancer patients and used second‐generation gene sequencing to characterize relevant gene mutations. The risk factors of different metastatic sites of real‐world lung cancer were explored to find the differentially expressed genes and risk factors in different metastatic organs, which laid a foundation for further study on the metastasis patterns and mechanisms of lung cancer. The clinical risk factors of tumor metastasis in 137 lung cancer patients who attended our department from May 2017 to March 2019 were retrospectively analyzed and grouped based on bone metastasis, brain metastasis, other distant metastasis, and no metastasis. Single‐ or multi‐factor logistic regression analysis was performed to analyze the effect of neutrophil/lymphocyte ratio/platelet/lymphocyte ratio/lymphocyte to monocyte ratio on platelets (PLTs) and bone metastasis by combining PLT values, age, pathology type, gender, and smoking history. Based on the presence or absence of bone metastasis, distal metastasis, and PLT values of lung cancer, 39 tissue specimens of primary lung cancer were taken for 773 gene grouping and gene mutation characterization. The tumor mutation load, gene copy number instability, microsatellite instability, and tumor heterogeneity among different groups were analyzed. Age and PLT level were independent risk factors for bone metastasis and distal metastasis, but not for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated PLT group. PLT values were an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. RB1 gene mutation was significantly associated with bone metastasis. Age and platelet level were independent risk factors for bone metastasis and distal bone metastasis, but age and platelet level were not risk factors for brain metastasis. The RB1 gene was mutated during bone metastasis, and tumor heterogeneity was less in the elevated platelet group. Platelet values are an independent risk factor for distant metastases from lung cancer other than the brain. Age has a significant effect on bone metastasis formation. Mutations in the RB1 gene are significantly associated with bone metastasis.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34799997</pmid><doi>10.1002/cam4.4424</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-4817-1074</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-7634
ispartof Cancer medicine (Malden, MA), 2022-01, Vol.11 (1), p.268-280
issn 2045-7634
2045-7634
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0ce17a141e1344789754da4907e54a5c
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley-Blackwell Titles (Open access); PubMed Central(OpenAccess)
subjects Age
Blood
Bone growth
Bone tumors
Brain cancer
Cancer Prevention
Copy number
gene mutation characteristics
Genes
Genomes
Leukocytes (neutrophilic)
Lung cancer
Lymphocytes
Medical prognosis
Metastases
Metastasis
metastatic sites
Microsatellite instability
Monocytes
Mutation
Patients
Platelets
Point mutation
Regression analysis
Retinoblastoma protein
Risk factors
Software
Tumors
title Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A19%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20risk%20factors%20and%20gene%20mutation%20characteristics%20of%20different%20metastatic%20sites%20of%20lung%20cancer&rft.jtitle=Cancer%20medicine%20(Malden,%20MA)&rft.au=Wang,%20Bin&rft.date=2022-01&rft.volume=11&rft.issue=1&rft.spage=268&rft.epage=280&rft.pages=268-280&rft.issn=2045-7634&rft.eissn=2045-7634&rft_id=info:doi/10.1002/cam4.4424&rft_dat=%3Cproquest_doaj_%3E2600287798%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5094-ccba976999dfef5a924ddc1de1523d9b7afb5972802dce6e8755012ba7763bd73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2613115233&rft_id=info:pmid/34799997&rfr_iscdi=true